Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Helicobacter pylori and gastric adenocarcinoma

Helicobacter pylori and gastric adenocarcinoma CLINICAL MICROBIOLOGY AND INFECTION Herrera, V., Parsonnet, J. 2009; 15 (11): 971-976

Abstract

Gastric cancer is the second most common cause of cancer death worldwide. A large body of evidence supports a causal role of Helicobacter pylori in the majority of gastric malignancies. Great strides have been made in understanding the pathogenesis of this relationship, but much remains to be learned. Moreover, because of the high prevalence of infection, the lack of definitive trials, and the challenges of H. pylori treatment, there remains no consensus on the role of routine screening and treatment of this infection to prevent cancer. This article reviews the current knowledge on H. pylori and gastric cancer and presents some of the clinical and public health challenges associated with this pathogen.

View details for DOI 10.1111/j.1469-0691.2009.03031.x

View details for Web of Science ID 000271055600003

View details for PubMedID 19874380